Factors Associated with Insufficient Liver Regeneration in Fulminant Hepatic Failure

暴发性肝衰竭中肝脏再生不足的相关因素

基本信息

  • 批准号:
    01480223
  • 负责人:
  • 金额:
    $ 4.29万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1989
  • 资助国家:
    日本
  • 起止时间:
    1989 至 1990
  • 项目状态:
    已结题

项目摘要

The aim of this project is to find factors associated with insufficient liver regeneration in fulminant hepatic failure. The following results have been obtained.1) In massive hepatic necrosis induced in rats by a hepatotoxin, fibrin deposition in the hepatic sinusoids was seen in association with endothelial cell destruction. Such massive hepatic necrosis was also observed when rats received endotoxin following hepatic macrophage activation by administration of killed Corynebacterium parvum or after partial hepatectomy.2) When rats received putrescine essential for liver regeneration following partial hepatectomy, hepatic DNA synthesis was enhanced with increased hepatic putrescine content, Insulin. glucagon or epidermal growth factor increased hepatic putrescine content through enhancing mRNA content and/or altering posttranscriptional regulation of ornithine decarboxylase, the key enzyme of polyamine production, thus suggesting that polyamine metabolism in the liver after partial hepatectomy may provide a useful tool for evaluation of action sites of hepatotrophic factors.3) Rat plasma membrane was found to have both stimulatory and inhibitory factors for DNA synthesis by rat hepatocytes in primary culture in the presence of epidermal growth factor or hepatocytes growth factor. The stimulatory factor seemed to be protein in character.4) In rats with massive hepatic necrosis secondary to fibrin deposition in the hepatic sinusoids, prothrombin time was negatively correlated with hepatic DNA synthesis. The necrosis was attenuated by treatment with anticoagulant infusion. When plasma membrane was obtained from rats given a hepatotoxin, its stimulatory potential for liver proliferation almost disappeared. Circulatory disturbance in the liver and loss of such stimulatory potential of liver plasma membrane may contribute to insufficient liver regeneration in fulminant hepatic failure.
该项目的目的是寻找与爆发性肝衰竭中肝脏再生不足相关的因素。结果表明:1)在肝毒素诱导的大鼠肝大面积坏死中,肝窦内纤维蛋白沉积与内皮细胞破坏有关。当大鼠在通过施用杀死的短小棒状杆菌激活肝巨噬细胞后或在部分肝切除术后接受内毒素时,也观察到这种大面积肝坏死。2)当大鼠在部分肝切除术后接受对肝再生至关重要的腐胺时,肝DNA合成随着肝腐胺含量、胰岛素的增加而增强。胰高血糖素或表皮生长因子通过增加mRNA含量和/或改变鸟氨酸脱羧酶(多胺产生的关键酶)的转录后调节来增加肝腐胺含量,因此,部分肝切除术后肝脏中的多胺代谢可能为评估肝营养因子的作用位点提供有用的工具。在原代培养的大鼠肝细胞中,在表皮生长因子或肝细胞生长因子的存在下,发现大鼠质膜具有刺激和抑制大鼠肝细胞DNA合成的因子。4)在继发于肝窦纤维蛋白沉积的大面积肝坏死大鼠中,凝血酶原时间与肝DNA合成呈负相关。通过抗凝剂输注治疗可减轻坏死。当从给予肝毒素的大鼠获得质膜时,其对肝增殖的刺激潜力几乎消失。肝循环障碍和肝细胞膜的这种刺激潜力的丧失可能导致暴发性肝功能衰竭时肝再生不足。

项目成果

期刊论文数量(103)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fujiwara K.: "Activated Kupffer Cells as a Factor of Massive Hepatic Necrosis after Liver Resection." HepatoーGastroenterology. 37. 194-197 (1990)
Fujiwara K.:“肝切除后激活的库普弗细胞是大面积肝坏死的一个因素。” 37. 194-197 (1990)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hirata K.: "Possible Contribution of Protein Kinase C Activation to Priming for DNA Synthesis Induced by Epidermal Growth Factor with Insulin and its Inhibition by Plasma Membrane in Primary Cultured Rat Hepatocytes." Biochem.Biophys.Res.Comm.171. 1093-10
Hirata K.:“蛋白激酶 C 激活可能对表皮生长因子与胰岛素诱导的 DNA 合成启动的贡献及其在原代培养大鼠肝细胞中质膜的抑制作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
YAMADA S, MOCHIDA S, OHNO A, HIRATA K, OGATA I, OHTA Y, FUJIWARA K.: "Evidence for Enhanced Function of Hepatic Macrophages after Long-term Ethanol Feeding in Rats." Liver.
YAMADA S、MOCHIDA S、OHNO A、HIRATA K、OGATA I、OHTA Y、FUJIWARA K.:“长期喂食乙醇后大鼠肝巨噬细胞功能增强的证据”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hirata K.: "Rat liver plasma membrane has both stimulatory and inhibitory factors for DNA synthesis by primary cultured rat hepatocytes in the presence of epidermal growth factor and insulin" Biochem.Biophys.Res.Commun.
Hirata K.:“在表皮生长因子和胰岛素存在下,原代培养的大鼠肝细胞的 DNA 合成对大鼠肝脏质膜具有刺激和抑制因子”Biochem.Biophys.Res.Commun。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomiyama T.: "Plasma alpha2-plasmin inhibitor-plasmin complex and FDPD-Dimer infulminant hepatic failure" Throm.Res.53. 253-260 (1989)
Tomiyama T.:“血浆 α2-纤溶酶抑制剂-纤溶酶复合物和 FDPD-二聚体暴发性肝衰竭”Throm.Res.53。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUJIWARA Kenji其他文献

FUJIWARA Kenji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUJIWARA Kenji', 18)}}的其他基金

Suppression of Pancreatic cancer neural invasion by regulation of Axon guidance molecule
调控Axon引导分子抑制胰腺癌神经侵袭
  • 批准号:
    20K22817
  • 财政年份:
    2020
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
NQR Study of Superconducting Mechanism mediated by Valence Fluctuations
价态涨落介导的超导机制的NQR研究
  • 批准号:
    21540338
  • 财政年份:
    2009
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetic Polymorphisms in Promoter Regions of Osteopontin Gene as Host Factors to Determine Th1 Immune Reactions against Hepatitis Virus.
骨桥蛋白基因启动子区的遗传多态性作为宿主因素确定针对肝炎病毒的 Th1 免疫反应。
  • 批准号:
    14370191
  • 财政年份:
    2002
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on Strategies for Non-Heart Beating Liver
肝脏无心跳治疗策略研究
  • 批准号:
    11470137
  • 财政年份:
    1999
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
New devices in anticoagulant therapy for massive hepatic necrosis through sinusoidal fibrin deposition
通过肝窦纤维蛋白沉积抗凝治疗大面积肝坏死的新装置
  • 批准号:
    06454258
  • 财政年份:
    1994
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Purification of hepatocyte comitogenic factor in plasma membrane and its action site (s) in hepatocyte proliferation.
质膜中肝细胞有丝分裂因子的纯化及其在肝细胞增殖中的作用位点。
  • 批准号:
    04454240
  • 财政年份:
    1992
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
ROLE OF SUPEROXIDE FROM MACROPHAGES IN HEPATIC FIBROSIS
巨噬细胞超氧化物在肝纤维化中的作用
  • 批准号:
    60480207
  • 财政年份:
    1985
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Senolytic trial for Aged Liver Regeneration Failure
老年肝脏再生失败的 Senolytic 试验
  • 批准号:
    23K19457
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The role of liver progenitor cells in liver regeneration
肝祖细胞在肝再生中的作用
  • 批准号:
    10607301
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
Promoting in vitro propagation of primary human hepatocytes as organoids using cues from natural liver regeneration
利用自然肝再生的线索促进原代人肝细胞作为类器官的体外增殖
  • 批准号:
    471981
  • 财政年份:
    2022
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Fellowship Programs
A new role of pancreatic growth-related factors (REG3) in two-staged rapid liver regeneration
胰腺生长相关因子(REG3)在两阶段快速肝再生中的新作用
  • 批准号:
    22K08817
  • 财政年份:
    2022
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Restoration and preservation of hepatic cardiolipin levels promotes liver regeneration in AH
肝心磷脂水平的恢复和保存促进 AH 中的肝再生
  • 批准号:
    10708057
  • 财政年份:
    2022
  • 资助金额:
    $ 4.29万
  • 项目类别:
Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration
VEGFA 在利用胆管细胞驱动的肝再生中的作用的研究
  • 批准号:
    10631156
  • 财政年份:
    2022
  • 资助金额:
    $ 4.29万
  • 项目类别:
The cell identification research of bone marrow drived liver repaired cell in the new liver regeneration therapy
新型肝再生疗法中骨髓驱动的肝修复细胞的细胞鉴定研究
  • 批准号:
    22K08057
  • 财政年份:
    2022
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
de novo approach to liver regeneration and liver disease focusing on PUFA containing phospholipids
以含有磷脂的 PUFA 为重点的肝再生和肝病从头方法
  • 批准号:
    22K08788
  • 财政年份:
    2022
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Do Revival Stem Cells Contribute to Liver Regeneration?
复兴干细胞有助于肝脏再生吗?
  • 批准号:
    RGPIN-2020-07168
  • 财政年份:
    2022
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Discovery Grants Program - Individual
Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration
VEGFA 在利用胆管细胞驱动的肝再生中的作用的研究
  • 批准号:
    10501501
  • 财政年份:
    2022
  • 资助金额:
    $ 4.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了